Drug development requires integrating multi-disciplinary business, regulatory and scientific activities. To successfully support a client’s program, it is imperative to provide advice and services that support all three…
Learn how to accelerate and de-risk clinical-stage drug programs by understanding phase-appropriate strategies that can give your molecule the best chance for success!
Summary: Listen in as experts Sherief Shaaban from Catalent and Kurt von Emster of Abingworth discuss taking a drug from concept to a tangible solution with a renewed focus on milestones, timelines, and efficiencies. Learn how biotechs are reconsidering strategic partnerships to better navigate development pathways, accelerate timelines, avoid common pitfalls, and stretch limited capital further than before.
Learn how to accelerate and de-risk clinical-stage drug programs by understanding phase-appropriate strategies that can give your molecule the best chance for success!
Listen to this webinar to hear experts share insights into developing intranasal vaccine analytical tools, how to improve the speed and quality of critical batch release and characterization assays and the importance of device selection in determining product performance.
